? 發問時間: 健康其他:保健 · 1 0 年前

請幫忙用APA最新版修正

請依照APA最新版格式幫我修正以下寫法,感恩喔

1.鄭弘裕、簡世霖(2006)‧糖尿病足‧慈濟醫學雜誌,18(1)

37-44。

2.呂榮國(2002,10月)‧糖尿病神經病變‧當代醫學,29(10)

45-50.

3.張曉婷、杜明勳(2005,4月)‧糖尿病神經病變-診斷及處

置‧基層醫學,20(4),84-88。

4.張曉婷、杜明勳(2005,9月)‧糖尿病神經病變-自主神經

病變‧基層醫學,20(9),236-239。

5.謝松蒼(2007,4月)‧周邊神經病變‧當代醫學,34(4),

9-14。

6.羅彥宇(2005,10月)‧我們的自主神經‧健康世界,238,

9-11.

7.蔡奉宏、陳青會、顏妙芬、康福瑩(2006,6月)‧第二型糖

尿病患足部潰瘍之相關因素探討‧實證護理,2(2),

137-145.

8.陳炳碩、蔡玉娟、陳宗鷹(2005,12月)‧神經病變性疼痛‧

慈濟醫學雜誌,17(6),71-73。

9.王錦滿、李麗芳、陳芝琪、黃美涓、鄧復旦、鄭寶釵(2005,3月)‧急性急症多發性神經病變:病例報告‧台灣復健醫學雜誌,33(1),55-62。

10.謝松蒼(2004,3月)‧免疫型神經病變的診斷與治療‧台灣

神經醫學會,13(1),39-45。

11.Kao-Ching Chen,Yen-Kuang Yang,Tzung-Lieh Yeh,I-Hui Lee,Po-See Chen,Ru-Band Lu,Ping-Yen Liu(2006),Potentially Arrhythmogenic Effects of Haloperidol and Olanzapine on Cardiac Autonomic Function-A Prelimin- ary Study,Tzu-Chi Med J,18(3),193-197。

12.Chun-Chiang Huang,Tien-Wen Chen,Ming-Cheng Weng,Chia-Ling Lee,Hsiang-Chieh Tseng,Mao-Hsiung Huang(2005),Effect of Glycemic Control on Electrophysiologic Chan- ges of Diabetic Neuropathy in Type 2 Diabetic PatientsThe Kaohsiung Journal of Medical Sciences,21(1),15-21.

13..Tsuan-Shih Yu,Chin-Feng Tseng,Lai-King Yeung,Kuo-Cheng,Chuan-Chieh Liu(2006), Carvedilol Aggravates Orthostatic Hypotension in a Diabetic Patient with Chronic Renal Failure, Acta Nephrologica, 20(2),120-125。

14.Brown MJ and Asbury AK: Diabetic Neuropathy. Ann Neurol. 15:2-12,1984.Spencer PS, Schanmburg HM. Classification of neurotoxic disease:Amorphological approach. In spencer OS & Schaumburg HH eds. Experimental and Clinical Neurotoxicology. Baltimore, W & W, 92-99,1980.

15.Greene DA, Latimer SA, Sima AAF. Sorbitol phosphoinositides and sodium

potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med,

316:599, 1987.

16.Greene DA, Latimer SA, Sima AAF. Pathogenesis and prevention of diabetic

neuropathy. Diabetes/Metab Rev. 4:201,1988.

1 個解答

評分
  • MEGUMI
    Lv 5
    1 0 年前
    最佳解答

    王錦滿、李麗芳、陳芝琪、黃美涓、鄧復旦、鄭寶釵(2005)‧急性急症多發性神經病變:病例報告‧台灣復健醫學雜誌,33(1),55-62。

    呂榮國(2002,10月)‧糖尿病神經病變‧當代醫學,29(10),45-50。

    張曉婷、杜明勳(2005)‧糖尿病神經病變-診斷及處置‧基層醫學,20(4),84-88。

    張曉婷、杜明勳(2005)‧糖尿病神經病變-自主神經病變‧基層醫學,20(9),36-239。

    陳炳碩、蔡玉娟、陳宗鷹(2005)‧神經病變性疼痛‧慈濟醫學雜誌,17(6),71-73。

    蔡奉宏、陳青會、顏妙芬、康福瑩(2006)‧第二型糖尿病患足部潰瘍之相關因素探討‧實證護理,2(2),137-145。

    鄭弘裕、簡世霖(2006)‧糖尿病足‧慈濟醫學雜誌,18(1),37-44。

    謝松蒼(2007)‧周邊神經病變‧當代醫學,34(4),9-14。

    謝松蒼(2004,3月)‧免疫型神經病變的診斷與治療‧台灣神經醫學會,13(1),39-45。

    羅彥宇(2005)‧我們的自主神經‧健康世界,238,9-11。

    Brown MJ and Asbury AK(1984). Diabetic Neuropathy. Ann Neurol. 15, 2-12.

    Chun-Chiang Huang, Tien-Wen Chen, Ming-Cheng Weng, Chia-Ling Lee, Hsiang-Chieh Tseng, Mao-Hsiung Huang(2005). Effect of Glycemic Control on Electrophysiologic Chan- ges of Diabetic Neuropathy in Type 2 Diabetic Patients. The Kaohsiung Journal of Medical Sciences, 21(1), 15-21.

    Greene DA, Latimer SA, Sima AAF(1988). Pathogenesis and prevention of diabetic neuropathy. Diabetes/Metab Rev. 4(201).

    Greene DA, Latimer SA, Sima AAF(1987). Sorbitol phosphoinositides and sodium potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med, 316(599).

    Kao-Ching Chen, Yen-Kuang Yang, Tzung-Lieh Yeh, I-Hui Lee, Po-See Chen, Ru-Band Lu, Ping-Yen Liu(2006). Potentially Arrhythmogenic Effects of Haloperidol and Olanzapine on Cardiac Autonomic Function-A Prelimin- ary Study, Tzu-Chi Med J, 18(3), 193-197.

    Spencer PS, Schanmburg HM(1980). Classification of neurotoxic disease:Amorphological approach. In spencer OS & Schaumburg HH eds. Experimental and Clinical Neurotoxicology. Baltimore, W & W, 92-99.

    Tsuan-Shih Yu, Chin-Feng Tseng, Lai-King Yeung, Kuo-Cheng, Chuan-Chieh Liu(2006), Carvedilol Aggravates Orthostatic Hypotension in a Diabetic Patient with Chronic Renal Failure, Acta Nephrologica, 20(2),120-125.

    礙於格式問題,有些沒辦法弄出來

    凡是太長會到第二行的,從第二行開始都要空兩格

    還有期刊名要斜體字喔。

還有問題?馬上發問,尋求解答。